Liposorber® DL-100

Liposorber® DL-100
Product Description

Kaneka pharma europe N.V has wide range of products which include liposorber® DL-100. It is used for removal of LDL-cholesterol (“bad cholesterol”) from whole blood. The complete system is comprised of a tubing set and two DL 50 dextran sulfate lipid-adsorption column. Contact us for more information.

Kaneka Eurogentec S.A.

  • BE
  • 2015
    On CPHI since

Kaneka Eurogentec S.A.

  • BE
  • 2015
    On CPHI since

More Products from Kaneka Eurogentec S.A. (4)

  • DX-21

    Product DX-21

    Kaneka pharma has a wide range of products which includes DX-21. It belongs to machine category. It is a computer-automated machine, controlling the entire lipid-apheresis procedure of whole blood treatment. It has high resolution 12 inch TFT color monitor, DHP (direct hemo perfusion) apheresis, etc. Conta...
  • Liposorber® DL-75

    Product Liposorber® DL-75

    Kaneka pharma europe N.V has wide range of products which include liposorber® DL-75. It is used for removal of LDL-cholesterol (“bad cholesterol”) from whole blood. The complete system is comprised of a tubing set and one DL-75 dextran sulfate lipid-adsorption column. It is indicated for the trea...
  • Liposorber® LA-15

    Product Liposorber® LA-15

    Kaneka pharma europe N.V has wide range of products which include liposorber® LA-15. It is used for removal of LDL-cholesterol (“bad cholesterol”) from whole blood. The complete system is comprised of a tubing set and two DL 50 dextran sulfate lipid-adsorption column. It is indicated for the trea...
  • MA-03

    Product MA-03

    Kaneka pharma europe N.V has wide range of products which includes MA-03. It belongs to machines category. It is a computer-automated machine, controlling the entire lipid-apheresis procedure of both, whole blood treatment and plasma lipid-apheresis treatment. It is enabled to record treatment's processes....

Kaneka Eurogentec S.A. resources (1)

  • News Kaneka officially starts continuous manufacturing in GMP condition

     Kaneka Corporation (Headquarters: Minato-ku, Tokyo; President: Mamoru Kadokura) installed continuous manufacturing equipment to be applied to small molecule pharmaceutical products at Kaneka Singapore Co. (Pte.) Ltd, (Headquarters: Singapore; President: Kazuhiko Yamada) and have started commercial production in GMP*1 condition June 2018.